SAGE Therapeutics (SAGE) Misses Q3 EPS by 10c
SAGE Therapeutics (NASDAQ: SAGE) reported Q3 EPS of ($0.50), $0.10 worse than the analyst estimate of ($0.40).
For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.
SAGE Therapeutics (NASDAQ: SAGE) reported Q3 EPS of ($0.50), $0.10 worse than the analyst estimate of ($0.40).
For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.